Israel-based startup specialising in AI vision care, NovaSight, has announced that it has finalised its round A financing totalling $8 million.
The round was led by venture capital firm, Rimonci Capital and joined by strategic investors from both pharmaceutical and medical device industries.
Prior to this round, the company raised $8 million for a total of $16 million.
WHY IT MATTERS
The funds...